ISSN: 2995-8067 | Quick Google Scholar
Organised by 
Welcome to IgMin, a leading platform dedicated to enhancing knowledge dissemination and professional growth across multiple fields of science, technology, and the humanities. We believe in the power of open access, collaboration, and innovation. Our goal is to provide individuals and organizations with the tools they need to succeed in the global knowledge economy.
We focus on enhancing knowledge exchange between disciplines to achieve rapid innovation.
Molecular Biomarkers play a crucial role in modern biology and medicine, serving as measurable indicators of biological processes, diseases, or the effects of treatment. These biomarkers can be molecules like DNA, RNA, proteins, or metabolites, and their presence, absence, or levels in biological fluids can provide critical insights into health and disease states. The study of molecular biomarkers is essential for understanding the molecular underpinnings of diseases, including cancer, neurodegenerative disorders, and cardiovascular diseases, enabling early diagnosis and personalized treatment approaches.
With the increasing emphasis on precision medicine, molecular biomarkers have become central to the development of targeted therapies and the optimization of drug treatments. Their use in diagnostic tools, prognostic assessments, and therapeutic monitoring is transforming the way diseases are understood and managed. Researchers in molecular biomarkers are uncovering new ways to detect diseases at their earliest stages, identify biomarkers for drug efficacy, and improve clinical outcomes, making them a key focus of both basic and applied research in biology and medicine.
Open Access Policy refers to a set of principles and guidelines aimed at providing unrestricted access to scholarly research and literature. It promotes the free availability and unrestricted use of research outputs, enabling researchers, students, and the general public to access, read, download, and distribute scholarly articles without financial or legal barriers. In this response, I will provide you with an overview of the history and latest resolutions related to Open Access Policy.
Global Visibility – Indexed in major databases
Fast Peer Review – Decision within 14–21 days
Open Access – Maximize readership and citation
Multidisciplinary Scope – Biology, Medicine and Engineering
Editorial Board Excellence – Global experts involved
University Library Indexing – Via OCLC
Permanent Archiving – CrossRef DOI
APC – Affordable APCs with discounts
Citation – High Citation Potential
Which articles are now trending?
